July 28, 2026

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A Biotech with Strong Revenue Growth and Analyst Confidence

Travere Therapeutics, Inc. (NASDAQ: TVTX) is capturing the attention of investors within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of $5.27..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Investors Eye 83.66% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a key player in the medical devices industry, is capturing investor attention with its impressive potential upside of 83.66%. This Carlsbad,..

Select Medical Holdings Corp (SEM) Stock Analysis: Navigating Stability with a 1.51% Dividend Yield

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, specifically within the medical care facilities industry, presents a compelling case of stability..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring the 67.69% Potential Upside for Investors

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, has caught the eye of investors with its ambitious pipeline and solid backing..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling an 85% Upside Potential with Innovative Immunotherapies

ImmunityBio, Inc. (NASDAQ: IBRX) is carving a niche for itself in the biotechnology sector, focusing on revolutionizing how the immune system is activated to combat cancer..

Clover Health Investments (CLOV) Stock Analysis: Exploring the Growth Potential with a 62% Revenue Surge

Clover Health Investments, Corp (CLOV), a key player in the healthcare plans sector, is navigating through a transformative phase. With a market cap of $2.25 billion,..

Progyny, Inc. (PGNY) Stock Analysis: Navigating the Fertility Benefits Market with Growth Potential

Progyny, Inc. (PGNY), a pioneer in fertility and family building benefits management, stands out in the healthcare plans sector with its innovative approach to providing comprehensive..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a Potential 8.37% Upside in the Medical Devices Industry

Haemonetics Corporation (NYSE: HAE), a prominent player in the healthcare sector, specifically within the medical devices industry, is generating significant buzz among investors. With a market..

BGM Group Ltd. (BGM): Investor Outlook on a Niche Healthcare Player Amidst 13.9% Revenue Growth

BGM Group Ltd. (BGM), a healthcare sector player operating out of China, has piqued investor interest with its recent financial performance, specifically a 13.9% revenue growth...

Organon & Co. (OGN) Stock Analysis: Navigating the Healthcare Market with a Strong Return on Equity

Organon & Co. (NYSE: OGN) stands as a formidable player in the healthcare sector, specifically in the realm of general drug manufacturing. With a market capitalization..

National HealthCare Corporation (NHC) Stock Analysis: A $3.53 Billion Healthcare Giant with a Strong Dividend Appeal

National HealthCare Corporation (NHC), a prominent player in the healthcare sector, operates in the medical care facilities industry, providing a broad range of services through its..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Exploring the 45.58% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with a compelling potential upside of 45.58%, attracting significant attention from..

Twist Bioscience (TWST) Investor Outlook: Navigating a 6.89% Upside in the Dynamic Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) has been making waves in the healthcare sector, specifically within the diagnostics and research industry. With a current market capitalization of..

QuidelOrtho Corporation (QDEL)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: A Potential 119% Upside Awaits

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a trailblazer in the biotechnology sector, is garnering significant attention from investors, thanks to a promising pipeline and substantial potential upside...

Immunovant, Inc. (IMVT) Stock Analysis: Uncovering a Promising 18.57% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is making waves in the biotechnology sector with its innovative approach to addressing autoimmune diseases. As a clinical-stage immunology company, Immunovant focuses..

Veracyte, Inc. (VCYT) Stock Analysis: 21.5% Revenue Growth Signals Strong Performance in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare diagnostics sector, presents an intriguing opportunity for investors seeking exposure to the rapidly evolving field of..

Agios Pharmaceuticals (AGIO) Stock Analysis: Navigating Growth with a 14.62% Potential Upside

For investors seeking exposure in the healthcare sector, particularly within the biotechnology industry, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling opportunity. With a market capitalization..

HUTCHMED (China) Limited (HCM) Stock Analysis: Is a 102% Upside Within Reach for This Healthcare Innovator?

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based leader in the healthcare sector, is capturing the attention of investors with its compelling growth potential. Specializing in..

Acadia Healthcare (ACHC) Stock Analysis: What Investors Need to Know Amidst Strong Analyst Consensus

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds